SYS-CON MEDIA Authors: Bob Gourley, Lori MacVittie, RealWire News Distribution, Cynthia Dunlop, Mark O'Neill

News Feed Item

Concise Analysis of Drug Solubility Technology: Spray Drying, Extrusion, and SCF

DUBLIN, February 11, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/tgtpbg/drug_solubility) has announced the addition of the "Concise Analysis of Drug Solubility Technology: Spray Drying, Extrusion, and SCF" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

As drug suppliers re-examine their business models to adjust to the rapidly evolving competitive landscape, the importance and impact of drug solubility on drug design and development is increasing in importance, extending beyond potential future drug therapeutics, and affecting current reformulation strategies as well.

As large-molecule therapeutics increase in number and as a percentage of all drug discoveries, the economic scales will tip in favor of those drug developers possessing the ability to engineer water-soluble formulations of inherently hydrophobic compounds.

The importance of solubilization technologies is also underscored by the capability they bestow on formulators attempting to re-formulate approved drugs approaching the end of their patent life. The survey examines established physical processes for improving and enhancing drug solubility, including spray dry dispersion, hot melt extrusion and supercritical fluid processing.

Highlights

  • Analyzes and evaluates drug formulation process technology improving the properties of insoluble poorly soluble and/or poorly absorbed drug candidates
  • Examines evolving market factors
  • Provides detailed assessments and status of commercial technologies designed to improve drug solubility
  • Profiles drug solubility technology market participants, their research activity, proprietary technology, and business strategies

Key Topics Covered:

Executive Summary

Drug Solubility Technology

Spray Dry Dispersion
Technology Market Drivers
Physicochemical Properties
Hot Melt Extrusion
Supercritical Fluid Processing

Approved Drug Products Formulated with SDD/HME/SFP

Acetaminophen
Nifedipine
Everolimus
Nabilone
Diethylpropion
Emend
Vildagliptin/Metformin
Clozapine
Fenofibrate
Griseofulvin
Ibuprofen
Etonogestrel
Etravirine
Verapamil
Liponavir+Ritonavir
Lacrisert
Tacrolimus
Rizatriptan
Naproxen
Norvir
Tapentadol
Etonogestrel, Ethinyl Estradiol
Itraconazole
Dexamethasone
Hydromorphone
Rapamune
Tricor, Triglide
Zoladex

Development/Pipeline Analysis and Assessment

Company Profiles

For more information visit http://www.researchandmarkets.com/research/tgtpbg/drug_solubility


Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.